My bookmarksSign up free
Source

2011/761/EU: Commission Implementing Decision of 24 November 2011 authorising the placing on the market of flavonoids from Glycyrrhiza glabra L. as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2011) 8362)

2011/761/EU: Commission Implementing Decision of 24 November 2011 authorising the placing on the market of flavonoids from Glycyrrhiza glabra L. as a novel food ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2011) 8362)

Regulation (EC) No 258/97 · Decision · 5 articles

Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗

Article 1

Open ↗

Flavonoids from Glycyrrhiza glabra L. (hereinafter referred to as ‘Glavonoid’), as specified in Annex I, may be placed on the market in the Union as a novel food ingredient for the uses specified in Annex II. Glavonoid shall not be sold to the final consumer as such.

Article 2

Open ↗

1.   The designation of flavonoids from Glycyrrhiza glabra L. authorised by this Decision on the labelling of the foodstuffs containing it shall be ‘flavonoids from Glycyrrhiza glabra L.’. 2.   There shall be a statement on the labelling of the foods where the product was added as a novel food ingredient indicating that: (a) the product should not be consumed by pregnant and breast feeding women, children and young adolescents; and (b) people taking prescription drugs should only consume the product under medical supervision; (c) a maximum of 120 mg of Glavonoid per day should be consumed. 3.   The amount of Glavonoid in the final food shall be indicated on the labelling of the food containing it. 4.   Beverages containing Glavonoid shall be presented to the final consumer as single portions.

Article 3

Open ↗

This Decision is addressed to Kaneka Pharma Europe NV, Triomflaan 173, 1160 Brussels, Belgium.

Supplementary provisions

ANNEX ISupplementary provisions

Open ↗

ANNEX I SPECIFICATIONS OF GLAVONOID Description Glavonoid is an extract derived from the roots or rootstock of Glycyrrhiza glabra L. by extraction with ethanol followed by further extraction of this ethanolic extract with medium-chain triglycerides. It is a dark-brown coloured liquid, containing 2,5 % to 3,5 % of glabridin. Specifications Parameter   Moisture less than 0,5 % Ash less than 0,1 % Peroxide value less than 0,5 meq/kg Glabridin 2,5 to 3,5 % of fat Glycyrrhizinic acid less than 0,005 % Fat including polyphenol-type substances not less than 99 % Protein less than 0,1 % Carbohydrates not detectable

ANNEX IISupplementary provisions

Open ↗

ANNEX II Food category Maximum content of Glavonoid Beverages based on milk Beverages based on yoghurt Beverages based on fruits or vegetables 120 mg per daily portion Food supplements 120 mg per portion of daily consumption

Other acts of the same type
Council Decision (EU) 2025/1407 of 8 July 2025 on the adoption by Bulgaria of the euro on 1 January 2026Council Decision (EU) 2025/1412 of 8 July 2025 amending Decision 1999/70/EC concerning the external auditors of the national central banks, as regards the external auditors of Hrvatska narodna bankaCouncil Decision (EU) 2025/1415 of 8 July 2025 on the position to be taken on behalf of the Union within the Assembly of the Special Union established by the Lisbon Agreement for the Protection of Appellations of Origin and their International Registration with regard to the proposed amendments to the Common Regulations under the Lisbon Agreement and the Geneva Act of that AgreementCouncil Decision (EU) 2025/1430 of 8 July 2025 on the position to be adopted, on behalf of the European Union, within the EEA Joint Committee concerning an amendment to Annex IV (Energy) to the EEA Agreement (RED II) (Text with EEA relevance)Council Decision (EU) 2025/1432 of 8 July 2025 on the position to be adopted, on behalf of the European Union, within the EEA Joint Committee concerning an amendment to Annex IV (Energy) to the EEA Agreement (EPBD) (Text with EEA relevance)Council Decision (EU) 2025/1436 of 8 July 2025 on the position to be taken on behalf of the European Union as regards the adoption of a decision of the Participants to the Arrangement on Officially Supported Export Credits on interest rate provisionsCouncil Decision (EU) 2025/1437 of 8 July 2025 establishing the position to be adopted on behalf of the European Union in the written procedure by the Participants to the Arrangement on Officially Supported Export Credits as regards the Common Line extending Ukraine’s eligibility for tied aidCommission Implementing Decision (EU) 2025/1445 of 8 July 2025 on the request for registration, pursuant to Regulation (EU) 2019/788 of the European Parliament and of the Council, of the European citizens’ initiative entitled Food is a Human Right for All! Guaranteeing healthy, just and sustainable food systems (notified under document C(2025) 4607)Council Decision (EU) 2025/1503 of 8 July 2025 on the signing, on behalf of the Union, of the Agreement between the European Union and the Government of the Republic of Kazakhstan on certain aspects of air servicesCouncil Decision (EU) 2025/1757 of 8 July 2025 on the position to be adopted, on behalf of the European Union, within the EEA Joint Committee concerning the amendment to Annex II (Technical regulations, standards, testing and certification) and Annex IV (Energy) to the EEA Agreement (EED) (Text with EEA relevance)Council Decision (EU) 2025/1976 of 8 July 2025 on the termination of the Voluntary Partnership Agreement between the European Union and the Republic of Cameroon on forest law enforcement, governance and trade in timber and derived products to the European Union (FLEGT)Commission Implementing Decision (EU) 2025/1324 of 7 July 2025 amending Implementing Decision (EU) 2019/1396 as regards certain administrative aspects related to expert panels and as regards the designation of an additional expert panel in the field of medical devices

Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.

Contents

What to look at next